Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018

Published:2021-11 Issue: Volume:112 Page:321-326
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Pfaller Michael A.,Shortridge Dee^ORCID,Harris Kelly A.^ORCID,Garrison Mark W.,DeRyke C. Andrew^ORCID,DePestel Daryl D.,Moise Pamela A.,Sader Helio S.

Funder

Merck & Co Inc

Merck Sharp and Dohme

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference35 articles.

1. PROPHETIC: prospective identification of pneumonia in hospitalized patients in the ICU;Bergin;Chest,2020

2. Molecular characterization of baseline Enterobacterales and Pseudomonas aeruginosa isolates from a Phase 3 nosocomial pneumonia (ASPECT-NP) clinical trial;Castanheira;Antimicrob Agents Chemother,2021

3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard,2018

4. Performance standards for antimicrobial susceptibility testing: 30th informational supplement. M100Ed30,2020

5. Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. hospitals (2011–2012);Farrell;Antimicrob Agents Chemother,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Antibiotics for Gram-Negative Nosocomial Pneumonia;Antibiotics;2024-07-05

2. A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2024-04-06

3. Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage;Journal of Antimicrobial Chemotherapy;2024-04-02

4. Management of Non-Ventilated hospital acquired pneumonia;Clinical Infection in Practice;2024-01

5. An overview of gram-negative bacteria with difficult-to-treat resistance: definition, prevalence, and treatment options;Expert Review of Anti-infective Therapy;2023-10-09